Data are available as presented in the paper and in the Supporting Information files. According to Danish legislation, our own approvals to use the Danish data sources for the current study do not allow us to distribute or make patient data directly available to other parties. Interested researchers may apply for data access through the Research Service at the Danish Health Data Authority (e-mail: <kd.atadsdehdnus@ecivresreksrof>; phone: +45 3268 5116). Up-to-date information on data access is available online (<http://sundhedsdatastyrelsen.dk/da/forskerservice>). Access to data from the Danish Health Data Authority requires approval from the Danish Data Protection Agency (<https://www.datatilsynet.dk/english/the-danish-data-protection-agency/introduction-to-the-danish-data-protection-agency/>). The authors do not have special access privileges to these data.

Introduction {#sec005}
============

Both a low Body Mass Index (BMI) (\<18.5 kg/m^2^, underweight) and a high BMI (≥30 kg/m^2^, obesity) are risk factors for increased morbidity, mortality, and adverse outcome of many diseases in the general population.\[[@pone.0195853.ref001]--[@pone.0195853.ref005]\] Despite that, knowledge is sparse on BMI values in patients acutely admitted to general hospitals, and on clinical characteristics and outcomes associated with different BMI levels. Earlier studies have suggested a protective effect of overweight or moderate obesity in patients acutely admitted to hospital with heart failure, hip fracture, or sepsis--the so-called obesity paradox.\[[@pone.0195853.ref006]--[@pone.0195853.ref011]\] In general population studies, newer meta-analyses have challenged the presence of any obesity paradox\[[@pone.0195853.ref005],[@pone.0195853.ref012]\] suggesting that previous findings have been biased by differences in clinical and lifestyle characteristics associated with different BMI ranges.\[[@pone.0195853.ref013]\] In general patient populations, such data are scarce.

Large-scale electronic patient data from clinical information systems constitute a potentially valuable and cost-efficient method of collecting data on patients' BMI, both for health care quality monitoring and for prognostic epidemiological research.\[[@pone.0195853.ref014]\] Studies have discussed the potential of using electronic health records, finding great opportunities of investigating disease development and treatment using electronic health records.\[[@pone.0195853.ref015]--[@pone.0195853.ref017]\] The Central Denmark Region Clinical Information System (CDRCIS) contains readily available data on BMI covering the entire hospital population in the Region, with virtually complete patient follow-up.\[[@pone.0195853.ref018]\]

In the present study, we aimed to examine BMI among patients acutely admitted to general hospitals and the association of BMI with 30-day mortality. We also examined characteristics associated with different BMI levels, including demographic characteristics, comorbidities, medication use, tobacco smoking, and reasons for admission.

Methods {#sec006}
=======

The Central Denmark Region has a mixed rural and urban population of approximately 1.27 million persons. In Denmark, medical records of individual patients are tracked using civil personal registration numbers. These unique identifiers, encoding sex and date of birth, have been assigned to all Danish residents since 1968. In the present study, we used civil personal registration numbers to link data from the Danish National Patient Registry (DNPR),\[[@pone.0195853.ref014]\] the Civil Registration System (CRS),\[[@pone.0195853.ref018]\] the CDRCIS, and the Aarhus University Prescription Database (AUPD).\[[@pone.0195853.ref019]\]

Study population {#sec007}
----------------

We used the DNPR to identify all individuals aged \> = 18 years in the Central Denmark Region with one or more acute inpatient hospital admissions recorded between January 1, 2011 and December 31, 2014 (N = 242,637). We then identified all patients with a body mass index (BMI) measurement in the CDRCIS recorded during their first acute hospital admission in the study period (N = 92,027, 38%). We grouped these BMI measurement according to standard categories: underweight (\<18.5 kg/m^2^), normal weight (18.5 to \<25 kg/m^2^), overweight (25 to \<30 kg/m^2^), obesity class I (30 to \<35 kg/m^2^), obesity class II (35 to \<40 kg/m^2^), and obesity class III (≥40 kg/m^2^).

30-day mortality {#sec008}
----------------

We ascertained complete 30-day mortality data from the Danish CRS system.\[[@pone.0195853.ref018]\]

Reason for hospital admission {#sec009}
-----------------------------

In each BMI category, we used the primary (first-listed) discharge diagnosis code recorded in the DNPR to identify the main reason for the first acute inpatient admission during the study period. We then examined 10 primary *International Classification of Diseases*, *Tenth Revision* (ICD-10) diagnoses that have been commonly related to either high or low BMI in the literature: femur fracture\[[@pone.0195853.ref020],[@pone.0195853.ref021]\] abdominal pain, angina,\[[@pone.0195853.ref022]\] atrial fibrillation,\[[@pone.0195853.ref023]\] pneumonia,\[[@pone.0195853.ref024],[@pone.0195853.ref025]\] chronic obstructive pulmonary disease \[COPD\], \[[@pone.0195853.ref005],[@pone.0195853.ref026],[@pone.0195853.ref027]\] type 2 diabetes \[T2D\],\[[@pone.0195853.ref028]\] erysipelas,\[[@pone.0195853.ref029],[@pone.0195853.ref030]\] cholelithiasis,\[[@pone.0195853.ref031]\] and sleep disturbances \[[@pone.0195853.ref032]\] (see [S1 Table](#pone.0195853.s001){ref-type="supplementary-material"} for codes). Second, we grouped patients according to major disease categories in ICD-10 ([S1 Table](#pone.0195853.s001){ref-type="supplementary-material"}).

Comorbidity {#sec010}
-----------

Based on DNPR data, we summarized each patient's comorbidity history based on hospital contacts during the five years prior to the admission date, according to 19 disease categories included in the Charlson Comorbidity Index (CCI).\[[@pone.0195853.ref033]\] We grouped patients by overall level of comorbidity, defined as a CCI score of 0 (no comorbidity recorded), 1--2 (moderate comorbidity), and 3+ (severe comorbidity) (see [S3](#pone.0195853.s003){ref-type="supplementary-material"} and [S4](#pone.0195853.s004){ref-type="supplementary-material"} Tables).

Smoking {#sec011}
-------

We used data from the CDRCIS to categorize patients' tobacco smoking status on the hospital admission date as follows: no smoking, current smoking, former smoking, or occasional smoking.

Medication use {#sec012}
--------------

We obtained individual-level information from the AUPD on prescription medications redeemed within 180 days before the hospital admission, and classified patients as users/non-users of anti-hypertensive medications, glucose-lowering medications, lipid-lowering medications, antidepressant or anxiolytic medications, prescription painkillers, inhalants for obstructive airway diseases, glucocorticoids, and medications for gastric disorders (see [S5 Table](#pone.0195853.s005){ref-type="supplementary-material"} for codes).

Statistical analyses {#sec013}
--------------------

We first ascertained the BMI distribution in the study population. We then tabulated demographic variables (sex and age), CCI score (none, moderate, or severe), number of admissions, hospital and department type, and smoking status (categorized as above). We calculated 30-day mortality proportions for each predefined BMI category and estimated mortality odds ratios (ORs), using BMI 18.5 to \<25 kg/m^2^ as reference category. We also calculated the OR adjusted for age and smoking status (adjusted OR, aOR), to assess if associations with BMI were independent of age and smoking. We refrained from further adjustments, as the order of factors in the causal pathway is impossible to disentangle in a cross-sectional design; factors such as comorbidities and medications may thus be mediators of any BMI effect on mortality rather than confounders. We presented graphically the proportions of users of selected medications and important causes of admission by BMI category, and further tabulated hospital contacts according to primary ICD-10 diagnosis chapters. We also calculated the prevalence ratios of causes of admission, using BMI 18.5 to \<25 kg/m^2^ as reference category.

Our study followed the RECORD guidelines,\[[@pone.0195853.ref034]\] and all data were fully anonymized before we accessed them. The study was approved by the Danish Data Protection Agency (Record Number KEA-2016-26). According to Danish legislation, registry-based studies do not require separate approval from the Danish Scientific Ethics Committee, nor do they require a written consent from the patients. The source data files were kept by the Central Denmark region and only files with the needed variables were exported to the Department of Clinical Epidemiology for research purposes. Only structured data were exported and the unique personal identifier (the CPR number) were encrypted in all data files. Personal variables like names, addresses etc. were excluded in all data files before transmission. Patients did not provide a written consent as the The Danish Act on Processing of Personal Data (Persondataloven) provides the legal basis for the ability of public institutions, including universities, to retain person-identifiable health data for research purposes. In addition, use of these data required a project-specific permission from the Data Protection Agency (Datatilsynet, [www.datatilsynet.dk](http://www.datatilsynet.dk/)).

Results {#sec014}
=======

BMI distribution in hospitalized patients {#sec015}
-----------------------------------------

Among 92,027 acutely admitted patients (median age 62 years, 50.5% male), the BMI distribution was as follows: underweight: 4.0%, normal weight: 41.8%, overweight: 33.8%, obesity class I: 13.9%, obesity class II: 4.4%, and obesity class III: 2.1% ([Table 1](#pone.0195853.t001){ref-type="table"}).

10.1371/journal.pone.0195853.t001

###### Characteristics of 92,027 patients acutely admitted to hospital in the Central Denmark Region between 2011 and 2014.

![](pone.0195853.t001){#pone.0195853.t001g}

                                                     Total            BMI\<18.5 kg/m^2^   BMI 18.5 to 25 kg/m^2^   BMI 25 to 30 kg/m^2^   BMI 30 to 35 kg/m^2^   BMI 35 to 40 kg/m^2^   BMI \> 40 kg/m^2^   Obesity, all, BMI \> 30 kg/m^2^
  -------------------------------------------------- ---------------- ------------------- ------------------------ ---------------------- ---------------------- ---------------------- ------------------- ---------------------------------
  **Overall:**                                       92,027 (100)     3701 (100)          38,446 (100)             31,093 (100)           12,810 (100)           4048 (100)             1929 (100)          18,787 (100)
  **Sex**                                                                                                                                                                                                   
  Female, n (%)                                      45,570 (49.5)    2709 (73.2)         21,001 (54.6)            12,682 (40.8)          5791 (45.2)            2213 (54.7)            1174 (60.9)         9178 (48.9)
  Male, n (%)                                        46,457 (50.5)    992 (26.8)          17,445 (45.4)            18,411 (59.2)          7019 (54.8)            1835 (45.3)            755 (39.1)          9609 (51.1)
  **Age**, median (interquartile range)              62 (45, 74)      68 (48, 81)         62 (42, 76)              63 (48,74)             61 (47, 71)            57 (44, 68)            54 (41, 66)         59 (40,73)
  **Age group, years**                                                                                                                                                                                      
  18--29, n (%)                                      9436 (10.3)      532 (14.4)          5421 (14.1)              2201 (7.1)             804 (6.3)              320 (7.9)              158 (8.2)           1282 (6.8)
  30--39, n (%)                                      8251 (9)         198 (5.3)           3483 (9.1)               2604 (8.4)             1225 (9.6)             472 (11.7)             269 (13.9)          1966 (10.5)
  40--49, n (%)                                      11,187 (12.2)    250 (6.8)           4039 (10.5)              3963 (12.7)            1839 (14.4)            697 (17.2)             399 (20.7)          2935 (15.6)
  50--59, n (%)                                      14,087 (15.3)    402 (10.9)          5067 (13.2)              5097 (16.4)            2368 (18.5)            787 (19.4)             366 (19)            3521 (18.7)
  60--69, n (%)                                      18,824 (20.5)    614 (16.6)          6854 (17.8)              6945 (22.3)            3016 (23.5)            964 (23.8)             431 (22.3)          4411 (23.5)
  70--79, n (%)                                      16,822 (18.3)    691 (18.7)          6744 (17.5)              6190 (19.9)            2366 (18.5)            588 (14.5)             243 (12.6)          3197 (17.0)
  80--89, n (%)                                      10,995 (11.9)    735 (19.9)          5441 (14.2)              3489 (11.2)            1070 (8.4)             200 (4.9)              60 (3.1)            1330 (7.1)
  90--99, n (%)                                      2379 (2.6)       271 (7.3)           1372 (3.6)               592 (1.9)              121 (0.9)              20 (0.5)               3 (0.2)             144 (0.8)
  100+, n (%)                                        46 (0)           8 (0.2)             25 (0.1)                 12 (0)                 1 (0)                  0 (0)                  0 (0)               1 (0)
  **CCI level**                                                                                                                                                                                             
  No comorbidity reported                            163,554 (67.4)   2163 (58.4)         25580 (66.5)             20292 (65.3)           8409 (65.6)            2725 (67.3)            1279 (66.3)         12,413 (66.1)
  Moderate comorbidity                               62,875 (25.9)    1213 (32.8)         10373 (27)               9010 (29)              3605 (29.1)            1093 (27)              522 (27.1)          5220 (27.8)
  Severe comorbidity                                 16,208 (6.7)     325 (8.8)           2493 (6.5)               1791 (5.8)             796 (6.2)              230 (5.7)              128 (6.6)           1154 (6.1)
  **Year**                                                                                                                                                                                                  
  2011, n (%)                                        14,329 (15.6)    613 (16.6)          5806 (15.1)              4916 (15.8)            2031 (15.9)            661 (16.3)             302 (15.7)          2994 (15.9)
  2012, n (%)                                        22,285 (24.2)    999 (27)            9285 (24.2)              7535 (24.2)            3016 (23.5)            1007 (24.9)            443 (23)            4466 (23.8)
  2013, n (%)                                        26,807 (29.1)    1045 (28.2)         11,322 (29.4)            9068 (29.2)            3733 (29.1)            1120 (27.7)            519 (26.9)          5372 (28.6)
  2014, n (%)                                        28,606 (31.1)    1044 (28.2)         12,033 (31.3)            9574 (30.8)            4030 (31.5)            1260 (31.1)            665 (34.5)          5955 (31.7)
  **Number of acute admissions during 2011--2014**                                                                                                                                                          
  1, n (%)                                           50,565 (54.9)    1598 (43.2)         21,394 (55.6)            17,393 (55.9)          6973 (54.4)            2191 (54.1)            1016 (52.7)         10,180 (54.2)
  2, n (%)                                           19,319 (21)      886 (23.9)          7828 (20.4)              6532 (21)              2764 (21.6)            886 (21.9)             423 (21.9)          4073 (21.7)
  3, n (%)                                           8532 (9.3)       435 (11.8)          3511 (9.1)               2772 (8.9)             1227 (9.6)             418 (10.3)             169 (8.8)           1814 (9.7)
  4, n (%)                                           4783 (5.2)       298 (8.1)           1970 (5.1)               1553 (5)               661 (5.2)              192 (4.7)              109 (5.7)           962 (5.1)
  5--9, n (%)                                        7287 (7.9)       392 (10.6)          3136 (8.2)               2353 (7.6)             952 (7.4)              279 (6.9)              175 (9.1)           1406 (7.5)
  10--19, n (%)                                      1401 (1.5)       80 (2.2)            565 (1.5)                444 (1.4)              204 (1.6)              73 (1.8)               35 (1.8)            312 (1.7)
  20--29, n (%)                                      126 (0.1)        10 (0.3)            36 (0.1)                 42 (0.1)               27 (0.2)               9 (0.2)                2 (0.1)             38 (0.2)
  30+, n (%)                                         14 (0)           2 (0.1)             6 (0)                    4 (0)                  2 (0)                  0 (0)                  0 (0)               2 (0)
  **Hospital type**                                                                                                                                                                                         
  Provincial hospital, n (%)                         69,301 (75.3)    2747 (74.2)         28,248 (73.5)            23,605 (75.9)          9979 (77.9)            3166 (78.2)            1556 (80.7)         14,701 (78.3)
  University hospital, n (%)                         22,726 (24.7)    954 (25.8)          10,198 (26.5)            7488 (24.1)            2831 (22.1)            882 (21.8)             373 (19.3)          4086 (21.7)
  **Department type**                                                                                                                                                                                       
  Medical, n (%)                                     37,267 (40.5)    1533 (41.4)         15,069 (39.2)            13,017 (41.9)          5245 (40.9)            1640 (40.5)            763 (39.6)          7648 (40.7)
  Acute, n (%)                                       26,843 (29.2)    1118 (30.2)         10,830 (28.2)            9025 (29.0)            3954 (30.9)            1262 (31.2)            654 (33.9)          5870 (31.2)
  Surgical, n (%)                                    24,799 (26.9)    922 (24.9)          10,968 (28.5)            8186 (26.3)            3259 (25.4)            1015 (25.1)            449 (23.3)          4723 (25.1)
  Other, n (%)                                       3118 (3.4)       128 (3.5)           1579 (4.1)               865 (2.8)              352 (2.7)              131 (3.2)              63 (3.3)            546 (2.9)
  **Smoking status**                                                                                                                                                                                        
  Missing, n (%)                                     37,634 (40.9)    1634 (44.2)         16024 (41.7)             12518 (40.3)           5120 (40.0)            1576 (38.9)            762 (39.5)          7458 (39.7)
  Available smoking status                           54,393 (59.1)    2067 (55.8)         22422 (58.3)             18575 (59.7)           7690 (60.0)            2472 (61.1)            1167 (60.5)         11,329 (60.3)
  Never smoker, n (%)                                20,499 (37.7)    540 (26.1)          8521 (38.0)              7065 (38.0)            2876 (37.4)            1013 (41.0)            484 (41.5)          4373 (38.6)
  Former smoker, n (%)                               16,131 (29.7)    461 (22.3)          5805 (25.9)              6097 (32.8)            2649 (34.4)            753 (29.7)             366 (31.4)          3768 (33.3)
  Daily smoker, n (%)                                14,738 (27.1)    938 (45.4)          6711 (29.9)              4399 (23.7)            1810 (23.5)            610 (24.7)             270 (23.1)          2690 (23.7)
  Occasional smoker, n (%)                           3025 (5.6)       128 (6.2)           1385 (6.2)               735 (4.0)              355 (4.6)              96 (3.9)               47 (4.0)            498 (4.4)

Mortality {#sec016}
---------

Overall 30-day mortality was 2.3%. Compared with normal-weight patients (30-day mortality 2.8%), underweight patients had the highest 30-day mortality (7.5%, aOR: 2.37 (95% CI; 1.95--2.89)) and patients with overweight (aORs: 0.65 (95% CI; 0.56--0.76), and in obesity classes I and II had the lowest 30-day mortality (1.4%, aORs: 0.76 (95% CI; 0.61--0.94), and 0.86 (95% CI; 0.59--1.26), with crude differences diminishing substantially after adjustment for age and smoking differences ([Fig 1](#pone.0195853.g001){ref-type="fig"}, [Table 2](#pone.0195853.t002){ref-type="table"}).

![30-day mortality among patients acutely admitted, by BMI category.](pone.0195853.g001){#pone.0195853.g001}

10.1371/journal.pone.0195853.t002

###### Mortality odds ratios (ORs), using normal weight as reference.

![](pone.0195853.t002){#pone.0195853.t002g}

  -----------------------------------------------------------------------------------------------------------------------------
                                   30-day mortality, %   OR (95% CI)         OR (95% CI)\        OR (95% CI)\
                                                                             Adjusted for age    Adjusted for age and smoking
  -------------------------------- --------------------- ------------------- ------------------- ------------------------------
  **BMI \<18.5 kg/m**^**2**^       7.5                   2.81 (2.45--3.22)   2.17 (1.89--2.51)   2.37 (1.95--2.89)

  **BMI 18.5 to 25 kg/m**^**2**^   2.8                   Ref.                Ref.                Ref.

  **BMI 25 to 30 kg/m**^**2**^     1.6                   0.56 (0.51--0.63)   0.61 (0.55--0.68)   0.65 (0.56--0.76)

  **BMI 30 to 35 kg/m**^**2**^     1.4                   0.50 (0.43--0.58)   0.63 (0.54--0.74)   0.76 (0.61--0.94)

  **BMI 35 to 40 kg/m**^**2**^     1.4                   0.50 (0.38--0.65)   0.80 (0.61--1.05)   0.86 (0.59--1.26)

  **BMI \> 40 kg/m**^**2**^        1.7                   0.58 (0.41--0.83)   1.12 (0.78--1.60)   1.08 (0.64--1.82)
  -----------------------------------------------------------------------------------------------------------------------------

Reasons for admission {#sec017}
---------------------

Overall, reasons for acute hospital admission differed substantially by BMI range ([Fig 2](#pone.0195853.g002){ref-type="fig"}, Tables [3](#pone.0195853.t003){ref-type="table"} and [4](#pone.0195853.t004){ref-type="table"}, and [S2 Table](#pone.0195853.s002){ref-type="supplementary-material"}).

![Selected reasons for acute inpatient admission (first-listed diagnosis codes), by BMI category.](pone.0195853.g002){#pone.0195853.g002}

10.1371/journal.pone.0195853.t003

###### Primary discharge diagnosis codes according to ICD-10 chapters.

![](pone.0195853.t003){#pone.0195853.t003g}

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Disease category                                                       All patients\   BMI \<18.5 kg/m^2^\   BMI 18.5 to 25 kg/m^2^\   BMI 25 to 30 kg/m^2^\   BMI 30 to 35 kg/m^2^\   BMI 35 to 40 kg/m^2^\   BMI \> 40 kg/m^2^\
                                                                         N = 92027       N = 3701              N = 38446                 N = 31093               N = 12810               N = 4048                N = 1929
  ---------------------------------------------------------------------- --------------- --------------------- ------------------------- ----------------------- ----------------------- ----------------------- --------------------
  Infectious diseases including pneumonia                                3,510 (3.8)     154 (4.2)             1,437 (3.7)               1,090 (3.5)             498 (3.9)               200 (4.9)               131 (6.8)

  Neoplasms                                                              7,066 (7.7)     395 (10.7)            3,225 (8.4)               2,317 (7.5)             817 (6.4)               223 (5.5)               89 (4.6)

  Hematological diseases                                                 1,364 (1.5)     82 (2.2)              569 (1.5)                 413 (1.3)               202 (1.6)               68 (1.7)                30 (1.6)

  Endocrine, nutritional and metabolic disorders                         4,817 (5.2)     245 (6.6)             1,790 (4.7)               1,384 (4.5)             805 (6.3)               346 (8.5)               247 (12.8)

  Mental and behavioral disorders                                        868 (0.9)       65 (1.8)              413 (1.1)                 254 (0.8)               101 (0.8)               26 (0.6)                9 (0.5)

  Diseases of the nervous system                                         5,629 (6.1)     210 (5.7)             2,216 (5.8)               1,910 (6.1)             865 (6.8)               287 (7.1)               141 (7.3)

  Diseases of the eye and adnexa                                         2,520 (2.7)     103 (2.8)             1,024 (2.7)               822 (2.6)               367 (2.9)               129 (3.2)               75 (3.9)

  Diseases of the ear and mastoid process                                1,527 (1.7)     58 (1.6)              654 (1.7)                 538 (1.7)               193 (1.5)               63 (1.6)                21 (1.1)

  Diseases of the circulatory system                                     21,543 (23.4)   536 (14.5)            7,827 (20.4)              8,208 (26.4)            3,487 (27.2)            1,045 (25.8)            440 (22.8)

  Diseases of the respiratory system                                     7,740 (8.4)     645 (17.4)            3,369 (8.8)               2,233 (7.2)             965 (7.5)               337 (8.3)               191 (9.9)

  Diseases of the digestive system                                       11,666 (12.7)   441 (11.9)            4,700 (12.2)              3,975 (12.8)            1,759 (13.7)            527 (13.0)              264 (13.7)

  Diseases of the skin and subcutaneous tissue                           2,774 (3.0)     65 (1.8)              989 (2.6)                 978 (3.1)               466 (3.6)               179 (4.4)               97 (5.0)

  Diseases of the musculoskeletal system and connective tissue           6,855 (7.4)     246 (6.6)             2,686 (7.0)               2,366 (7.6)             1,051 (8.2)             355 (8.8)               151 (7.8)

  Diseases of the genitourinary system                                   5,910 (6.4)     219 (5.9)             2,486 (6.5)               1,945 (6.3)             817 (6.4)               288 (7.1)               155 (8.0)

  Pregnancy, childbirth and the puerperium                               1,319 (1.4)     36 (1.0)              693 (1.8)                 331 (1.1)               154 (1.2)               67 (1.7)                38 (2.0)

  Conditions originating in the perinatal period                         3 (0.0)         0 (0.0)               1 (0.0)                   2 (0.0)                 0 (0.0)                 0 (0.0)                 0 (0.0)

  Congenital malformations, deformations and chromosomal abnormalities   352 (0.4)       23 (0.6)              167 (0.4)                 88 (0.3)                47 (0.4)                21 (0.5)                6 (0.3)

  Symptoms, signs and abnormal clinical and laboratory findings          16,272 (17.7)   658 (17.8)            6,857 (17.8)              5,444 (17.5)            2,285 (17.8)            707 (17.5)              321 (16.6)

  Injury and poisoning                                                   15,822 (17.2)   646 (17.5)            7,556 (19.7)              4,946 (15.9)            1,860 (14.5)            549 (13.6)              265 (13.7)

  External causes of morbidity and mortality                             34 (0.0)        4 (0.1)               11 (0.0)                  14 (0.0)                4 (0.0)                 1 (0.0)                 0 (0.0)
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

10.1371/journal.pone.0195853.t004

###### Prevalence ratios (PRs) of discharge diagnosis codes according to ICD-10 chapters.

![](pone.0195853.t004){#pone.0195853.t004g}

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Disease category                                                       BMI \<18.5 kg/m^2^\   BMI 18.5 to 25 kg/m^2^\   BMI 25 to 30 kg/m^2^\   BMI 30 to 35 kg/m^2^\   BMI 35 to 40 kg/m^2^\   BMI \> 40 kg/m^2^\
                                                                         N = 3701              N = 38446                 N = 31093               N = 12810               N = 4048                N = 1929
  ---------------------------------------------------------------------- --------------------- ------------------------- ----------------------- ----------------------- ----------------------- --------------------
  Infectious diseases including pneumonia                                1.1 (0.9--1.3)        Ref.                      0.9 (0.9--1.0)          1.0 (0.9--1.1)          1.3 (1.1--1.5)          1.8 (1.5--2.2)

  Neoplasms                                                              1.3 (1.2--1.4)        Ref.                      0.9 (0.8--0.9)          0.8 (0.7--0.8)          0.7 (0.6--0.7)          0.6 (0.4--0.7)

  Hematological diseases                                                 1.5 (1.2--1.9)        Ref.                      0.9 (0.8--1.0)          1.1 (0.9--1.2)          1.1 (0.9--1.5)          1.1 (0.7--1.5)

  Endocrine, nutritional and metabolic disorders                         1.4 (1.2--1.6)        Ref.                      1.0 (0.9--1.0)          1.3 (1.2--1.5)          1.8 (1.6--2.1)          2.8 (2.4--3.1)

  Mental and behavioral disorders                                        1.6 (1.3--2.1)        Ref.                      0.8 (0.7--0.9)          0.7 (0.6--0.9)          0.6 (0.4--0.9)          0.4 (0.2--0.8)

  Diseases of the nervous system                                         1.0 (0.9--1.1)        Ref.                      1.1 (1.0--1.1)          1.2 (1.1--1.3)          1.2 (1.1--1.4)          1.3 (1.1--1.5)

  Diseases of the eye and adnexa                                         1.0 (0.9--1.3)        Ref.                      1.0 (0.9--1.1)          1.1 (1.0--1.2)          1.2 (1.0--1.4)          1.5 (1.2--1.8)

  Diseases of the ear and mastoid process                                0.9 (0.7--1.2)        Ref.                      1.0 (0.9--1.1)          0.9 (0.8--1.0)          0.9 (0.7--1.2)          0.6 (0.4--1.0)

  Diseases of the circulatory system                                     0.7 (0.7--0.8)        Ref.                      1.3 (1.3--1.3)          1.3 (1.3--1.4)          1.3 (1.2--1.3)          1.1 (1.0--1.2)

  Diseases of the respiratory system                                     2.0 (1.8--2.1)        Ref.                      0.8 (0.8--0.9)          0.9 (0.8--0.9)          1.0 (0.9--1.1)          1.1 (1.0--1.3)

  Diseases of the digestive system                                       1.0 (0.9--1.1)        Ref.                      1.0 (1.0--1.1)          1.1 (1.1--1.2)          1.1 (1.0--1.2)          1.1 (1.0--1.3)

  Diseases of the skin and subcutaneous tissue                           0.7 (0.5--0.9)        Ref.                      1.2 (1.1--1.3)          1.4 (1.3--1.6)          1.7 (1.5--2.0)          2.0 (1.6--2.4)

  Diseases of the musculoskeletal system and connective tissue           1.0 (0.8--1.1)        Ref.                      1.1 (1.0--1.1)          1.2 (1.1--1.3)          1.3 (1.1--1.4)          1.1 (1.0--1.3)

  Diseases of the genitourinary system                                   0.9 (0.8--1.0)        Ref.                      1.0 (0.9--1.0)          1.0 (0.9--1.1)          1.1 (1.0--1.2)          1.2 (1.1--1.5)

  Pregnancy, childbirth and the puerperium                               0.5 (0.4--0.8)        Ref.                      0.6 (0.5--0.7)          0.7 (0.6--0.8)          0.9 (0.7--1.2)          1.1 (0.8--1.5)

  Conditions originating in the perinatal period                         0.0 (.-.)             Ref.                      2.5 (0.2--27.3)         0.0 (.-.)               0.0 (.-.)               0.0 (.-.)

  Congenital malformations, deformations and chromosomal abnormalities   1.4 (0.9--2.2)        Ref.                      0.7 (0.5--0.8)          0.8 (0.6--1.2)          1.2 (0.8--1.9)          0.7 (0.3--1.6)

  Symptoms, signs and abnormal clinical and laboratory findings          1.0 (0.9--1.1)        Ref.                      1.0 (1.0--1.0)          1.0 (1.0--1.0)          1.0 (0.9--1.1)          0.9 (0.8--1.0)

  Injury and poisoning                                                   0.9 (0.8--1.0)        Ref.                      0.8 (0.8--0.8)          0.7 (0.7--0.8)          0.7 (0.6--0.7)          0.7 (0.6--0.8)

  External causes of morbidity and mortality                             3.8 (1.2--11.9)       Ref.                      1.6 (0.7--3.5)          1.1 (0.3--3.4)          0.9 (0.1--6.7)          0.0 (.-.)
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Compared with normal-weight individuals as reference (20.4%, [Table 2](#pone.0195853.t002){ref-type="table"}), we observed large differences in the proportion of admissions due to diseases of the circulatory system among patients with underweight: 14.5%, PR: 0.7 (95% CI; 0.7--0.8), overweight: 26.4%, PR: 1.3 (95% CI; 1.3--1.4), and obesity class III: 22.8%, PR: 1.1 (95% CI; 1.0--1.2)). Patients with normal weight had a high frequency of admissions due to injuries (*e*.*g*., fractures) and poisoning (underweight: 17.5%, normal weight: 19.7%, overweight: 15.9%, and obesity class III: 13.7%) ([Table 3](#pone.0195853.t003){ref-type="table"}, see [S1 Table](#pone.0195853.s001){ref-type="supplementary-material"} for diagnosis codes). For respiratory diseases (*e*.*g*., COPD), we observed a J-shaped association based on visual judgment, with the highest prevalence proportions among patients with underweight (17.4%, PR: 2.0 (95% CI; 1.8--2.1)) and among patients in obesity class III (9.9%, PR: 1.1 (95% CI; 1.0--1.3)) (Tables [3](#pone.0195853.t003){ref-type="table"} and [4](#pone.0195853.t004){ref-type="table"}). Other diseases, including diseases of the digestive system or "symptoms, signs and abnormal clinical findings" had similar frequencies according to BMI category. For several specific conditions within these disease categories, findings were comparable (see [Fig 2](#pone.0195853.g002){ref-type="fig"} and description below).

Patients with underweight {#sec018}
-------------------------

Patients with underweight differed substantially from patients in the other BMI categories. Median age was high \[68 years (IQR: 48--81 years)\]; 26.8% were male; many patients smoked daily (45.4%); and 41.6% had previous hospital-diagnosed comorbidities ([Table 1](#pone.0195853.t001){ref-type="table"}). Admissions due to respiratory diseases were more frequent than in the other BMI categories: chronic obstructive pulmonary disease accounted for 6.0% of admissions, pneumonia: 4.5%, pneumonia: 3.8%, bacterial pneumonia for 2.0%, respiratory failure for 1.8%, acute lower respiratory infection for 1.7%, and fracture of the femur for 6.8% ([Fig 2](#pone.0195853.g002){ref-type="fig"}, [S2 Table](#pone.0195853.s002){ref-type="supplementary-material"}).

Among underweight patients, 38.0% were prescribed painkillers, 38.1% used antibiotic medications, 23.0% used antidepressant and anxiolytic medications; 20.1% used inhalants for obstructive airway diseases, 18.1% used drugs to treat gastric acid-related diseases, and 11.7% used glucocorticoids ([Fig 3](#pone.0195853.g003){ref-type="fig"}, [S6 Table](#pone.0195853.s006){ref-type="supplementary-material"}).

![Current use of selected prescription drugs, by BMI category.](pone.0195853.g003){#pone.0195853.g003}

Patients with normal weight {#sec019}
---------------------------

Among patients with normal weight, the median age was 62 years (IQR: 42--76 years), 45.4% were male, 66.5% had no comorbidities, 29.9% smoked daily, and 30-day mortality was 2.8% ([Table 1](#pone.0195853.t001){ref-type="table"}). The three most common causes of hospital admission were abdominal and pelvic pain (5.3%), fracture of femur (4.2%), and atrial fibrillation and flutter (3.3%) ([Fig 2](#pone.0195853.g002){ref-type="fig"} and [S2 Table](#pone.0195853.s002){ref-type="supplementary-material"}). Among patients with normal weight, 68.9% were users of any medication ([Fig 3](#pone.0195853.g003){ref-type="fig"}, [S6 Table](#pone.0195853.s006){ref-type="supplementary-material"}).

Patients with overweight {#sec020}
------------------------

Among overweight patients, the median age was 63 years (IQR: 48--74 years), 59.2% were male, 65.3% had no comorbidities, 23.7% smoked daily, and 30-day mortality was 1.6% ([Table 1](#pone.0195853.t001){ref-type="table"}). Admission patterns were similar to those of patients with normal weight. However, prevalence of cholelithiasis was higher (1.8%) ([Fig 1](#pone.0195853.g001){ref-type="fig"} and [S2 Table](#pone.0195853.s002){ref-type="supplementary-material"}). The overall prevalence of medication use was 72.9% ([Fig 3](#pone.0195853.g003){ref-type="fig"}, [S6 Table](#pone.0195853.s006){ref-type="supplementary-material"}). The use of antibiotic medications (28.7%), antidepressants and anxiolytic medications (16.0%), glucocorticoids (10.5%), and inhalants for obstructive airway diseases (10.5%) was lower than in the other BMI categories ([Fig 3](#pone.0195853.g003){ref-type="fig"} and [S6 Table](#pone.0195853.s006){ref-type="supplementary-material"}).

Patients with obesity {#sec021}
---------------------

Patients with BMI ≥30 were relatively young (59 years median), few patients smoked (24%), and 66.1% had no comorbidities.

The median age varied from 61 in obesity class I to 54 years in obesity class III ([Table 1](#pone.0195853.t001){ref-type="table"}). Male gender accounted for 39.1%-54.8% of persons in obesity classes I-III. Thirty-day mortality was lower among patients in obesity classes I and II (1.4%), compared to 1.7% among patients in obesity class III. Patients with obesity had a high overall prevalence of medication use: 78.1% in class I, 81.8% in class II, and 83.6% in class III ([Fig 3](#pone.0195853.g003){ref-type="fig"} and [S6 Table](#pone.0195853.s006){ref-type="supplementary-material"}). This included a high prevalence of users of glucose-lowering medications (14.9% to 23.6%), antihypertensive medications (21.5% to 21.5%), lipid-lowering medications (30.9% to 29.2%), and antibiotic medications (31.2% to 39.1%). Hospital admissions due to type 2 diabetes increased with higher BMI (obesity class I: 2.6%, obesity class II: 3.6%, and obesity class III: 6.0%) ([Fig 3](#pone.0195853.g003){ref-type="fig"} and [S2 Table](#pone.0195853.s002){ref-type="supplementary-material"}). Other common causes of hospitalization were cholelithiasis (2.5% to 2.7%), sleep disorders (1.3% to 3.2%), breathing abnormalities (1.3% to 2.4%), erysipelas (1.1% to 3.5%), cutaneous abscess, furuncle, and carbuncle (1.5% to 2.2%) and heart failure (1.6% to 2.0%).

Discussion {#sec022}
==========

To our knowledge, this is the first study to examine BMI distribution among patients acutely admitted to general hospitals in a setting with universal hospital coverage. This contrasts with previous studies which have examined BMI and mortality either in general populations of adults \[[@pone.0195853.ref003],[@pone.0195853.ref005]\] or among patients with specific diseases or inclusion criteria.\[[@pone.0195853.ref006]--[@pone.0195853.ref011]\]

When comparing our 92,027 hospitalized patients with Denmark's general population, a recent BMI survey in 2017 found that 2.7% of the Danish population had a self-reported BMI \<18.5 kg/m^2^, 47.4% had BMI ≥25 kg/m^2^, and 14.1% had BMI ≥30 kg/m^2^.\[[@pone.0195853.ref035]\] The corresponding numbers for our hospitalized cohort of 2.4%, 51.0%, and 16.8%, respectively, indicate a slight overrepresentation of patients with high BMI values. This may reflect a truly increased admission rate in underweight or overweight people, or alternatively, more complete BMI recording among hospitalized patients with high BMI.

Overall, we observed considerable differences in patient characteristics and causes of admissions according to BMI category. In line with previous studies on patients with acute admissions,\[[@pone.0195853.ref006]--[@pone.0195853.ref011]\] we found that patients with underweight had the highest 30-day mortality, while patients in obesity classes I and II had the lowest 30-day mortality, apparently related in part to their lower median age. Compared to patients with normal weight or obesity, patients with underweight were older, and more likely to be female, to have more comorbidities and more abnormal blood test results, and to have a higher prevalence of medication use and smoking. In contrast, patients with obesity were younger, had a lower frequency of smoking and lower use of several types of drugs, including antibiotic drugs and inhalants for obstructive airway diseases, but many more metabolic-syndrome-related risk factors.

It has been suggested that the higher mortality among patients with underweight in previous studies may be explained in part by an association between low BMI, tobacco smoking, and underlying illness leading to non-intentional weight loss. In contrast, our observation of a lower mortality in patients with overweight or obesity as compared with normal weight patients even after controlling for differences in age and smoking seems to confirm the 'obesity paradox'. \[[@pone.0195853.ref006]--[@pone.0195853.ref011],[@pone.0195853.ref036]\] Importantly, we found that patients with normal weight, overweight, and obesity were very similar with regards to both age distribution, comorbidity, and history of ever smoking. Obesity is associated with proinflammatory defenses and increased energy reserves, which may be protective in patients with acute or chronic disease.\[[@pone.0195853.ref037],[@pone.0195853.ref038]\] Some studies have reported an age-associated protective effect of overweight on mortality: the higher the age, the more protective is the effect of overweight on mortality.\[[@pone.0195853.ref036]\] Alternatively, a previous study suggested that a higher proportion of people with obesity may be admitted to hospital, despite similar or lower severity of illness as compared with normal weight individuals.\[[@pone.0195853.ref010]\] Any lowered admission threshold may cause surveillance bias and lead to underestimation of mortality in obese patients. Another possible explanation on the obesity paradox is the presence of "collider bias": a situation, where uncorrelated causes \[e.g, obesity and infections\] "collide" by each competing to trigger the same outcome \[e.g. heart failure\]--and in the cases where obesity is the cause, the course of the disease may be more mild than in the cases where other causes lead to the disease \[eg. infectious cardiomyopathy\].\[[@pone.0195853.ref039]\]

We found a close association between underweight and specific chronic conditions, including chronic pulmonary disease (COPD). Tobacco smoking, \[[@pone.0195853.ref005],[@pone.0195853.ref026],[@pone.0195853.ref027]\] known to have a great impact on disease patterns and mortality, was also more prevalent among underweight persons. These findings corroborate findings in previous cross sectional studies, in which smoking has been related to both underweight \[[@pone.0195853.ref040]\] and COPD \[[@pone.0195853.ref027]\] and COPD patients were more underweight than people without COPD.\[[@pone.0195853.ref041]\] Hospital admissions due to pneumonia also were frequent among patients with underweight, in line with a recent meta-analysis (N = 2,561,839 patients) that reported a relative risk of 1.8 of for community-acquired pneumonia among patients with underweight compared to patients with normal weight.\[[@pone.0195853.ref042]\] We found that fractures of the femur also were common among patients with underweight corroborating previous findings.\[[@pone.0195853.ref043]\] Underweight is a documented risk factor for osteoporotic fractures.\[[@pone.0195853.ref044]\] Although the mechanisms through which low BMI may affect bone mineral density are not completely understood, the low levels of hormones secreted in the adipose tissue, including estrogen, leptin, and interleukin-6, may be protective.\[[@pone.0195853.ref021],[@pone.0195853.ref045]\] Smoking is associated with low BMI,\[[@pone.0195853.ref040]\] low bone mineral density,\[[@pone.0195853.ref046]\] and fracture risk,\[[@pone.0195853.ref020]\] and likely contributed to the high number of observed fracture admissions.\[[@pone.0195853.ref021],[@pone.0195853.ref045]\]

Corroborating others' findings, \[[@pone.0195853.ref028]\] hospital admissions due to type 2 diabetes and use of drugs to treat metabolic syndrome-related diseases were common among patients with overweight and admissions due to type 2 diabetes and use of glucose-lowering drugs increased with increasing BMI (Figs [2](#pone.0195853.g002){ref-type="fig"} and [3](#pone.0195853.g003){ref-type="fig"}).\[[@pone.0195853.ref028]\] Cholelithiasis is also associated with obesity and the metabolic syndrome.\[[@pone.0195853.ref031]\] As seen in [Fig 2](#pone.0195853.g002){ref-type="fig"}, our results confirm the well-known association between obesity and obstructive sleep apnea.\[[@pone.0195853.ref047]\] Also infections including pneumonia and erysipelas increased with increasing BMI ([Fig 2](#pone.0195853.g002){ref-type="fig"}), pointing to an association between obesity and skin, wound, respiratory, and other infections, and overall use of antibiotics which is in line with previous studies.\[[@pone.0195853.ref024],[@pone.0195853.ref025],[@pone.0195853.ref029],[@pone.0195853.ref048]--[@pone.0195853.ref051]\] In contrast to previous findings, we found no clear association between atrial fibrillation and BMI.\[[@pone.0195853.ref023]\]

The gender distribution differed among the BMI groups: both among patients with underweight and severe obesity, there was a high proportion of females, which may affect the disease risk for e.g. angina pectoris.\[[@pone.0195853.ref052]\] Further studies are required to investigate the interaction between obesity outcomes and gender in more detail.

Strengths and limitations {#sec023}
-------------------------

The main strengths of the present study include its unique information on BMI on a very large sample size and the access to complete hospitalization and prescription records.

Our study has several potential limitations. Only 38% of all acutely admitted patients had their BMI measured, and BMI values are likely not missing completely at random. Health care professionals may have an inclination to weigh people with either very low or high BMI compared with patients with normal BMI. Thus, since our data are likely not a random sample of all acutely admitted patients, they cannot be used as an estimation for the BMI distribution of hospital admitted patients in general. However, we present data mostly stratified, and we may argue that within strata of BMI, missingness is at random, and that data per strata (for example, mortality) are not largely invalidated by missingness. Still information bias may have occurred if, theoretically, a larger proportion of critically versus non-critically ill patients with low BMI have their weight measured, while in patients with obesity, both critically and non-critically ill patients may have their BMI measured.

Although inaccurate diagnostic coding may be a concern for the patient characteristics we measured, the physician-coded diagnoses in the DNPR have been reported to be highly valid for many conditions.\[[@pone.0195853.ref014]\] Concerning prescriptions, the AUPD contains data on prescriptions filled,\[[@pone.0195853.ref019]\] but no information on actual medication intake. However, several studies have shown good agreement between self-reported medication use or medication use reported by general practitioners and prescriptions filled at pharmacies.\[[@pone.0195853.ref053]--[@pone.0195853.ref055]\] Finally, data on smoking status relied on information self-reported by patients to their physicians, as recorded in the Central Denmark Region clinical information system at time of admission, and patients may underreport their smoking behavior. However, we assume that this possible underreporting is non-differentially associated with BMI values.

Conclusion {#sec024}
----------

We have profiled acutely hospitalized patients in Denmark by their BMI. We documented a high short-term mortality among patients with underweight, however, we found evidence that clinical characteristics differ substantially by BMI category in hospitalized patients. Patients with underweight have a notably high frequency of smoking, admissions due to respiratory diseases, osteoporotic fractures, and comorbidity. Patients with obesity are often hospitalized due to skin infections, cholelithiasis, sleep disorders, diabetes, and heart failure. These data may prove valuable for future studies on the prognostic effect of BMI following hospital admission for a range of diseases.
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